CD274 and non-small cell lung carcinoma: In this study, we performed a meta-analysis between ATB use and clinic features, including ECOG score (≤), PD-L1 expression (<1%), non-small-cell lung cancer (NSCLC) patients, gender (male) and ICI therapy line (0–1 prior), which were shown in Supplementary Material.